European researchers report mixed results from long term follow-up of a trial that evaluated postoperative radiotherapy for prostate cancer. Men given immediate radiotherapy had better progression-free survival over 10 years than controls managed with a “wait and see” policy. However, this was true only when “progression” was …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking